Projects per year
Organisation profile
Organisation profile
宗旨:
促進本校生技醫藥商品化發展,提供一校三院同仁醫藥品研發服務,以開發具有創新性與前瞻性之生技醫藥產品開發為宗旨。
背景:
生技醫藥為我國重要產業,建立藥品及醫材開發的關鍵價值鏈平台是校園研究成果產業化最大的助力。為有效統整及加速本校之新藥及醫材研發能量,規劃成立臺北醫學大學生技醫藥商品化中心(TMU Biomedical Commercialization Center),藉由商品化中心跨院系所專業團隊間的整合運作,提供一校三院同仁生技藥品臨床前到IND申請之臨床前研究(pre-clinical study)諮詢與服務。此外,透過北醫事業發展處協助醫藥品商品化開發策略,包含藥物市場定位分析,法規、專利檢索和諮詢服務,技術轉移或尋求業界承接產學合作案,及衍生新創事業體之相關規劃。
目的:
整合新藥開發及醫療器材從臨床前研究到IND/IDE所需之技術發展平台(Research Development),提供校內外單位委託合作或共同開發之服務。
搭配事業發展處之資源協助擬定生技醫藥品商業化發展策略(Business Development)、專利布局及商業化輔導,以加速產出具有創新性與前瞻性的生技醫藥品。
初期以藥品的商業化平台為目標:規劃由藥物設計/合成與篩選、藥理活性、藥物動力學、藥物代謝、藥效、毒理、小試量產、製劑開發等提供平台服務。
Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
Che-Chang Chang
- The Ph.D. Program for Translational Medicine - Professor
- Graduate Institute of Biomedical Informatics - Joint-Appointment Associate Professor
- International Ph.D. Program for Translational Science - Joint-Appointment Associate Professor
- Ph.D. Program in Drug Discovery and Development Industry - Joint-Appointment Associate Professor
- Master Program in Clinical Genomics and Proteomics - Joint-Appointment Associate Professor
- International Master Program for Translational Science - Joint Appointment Associate Prfoessor
- TMU Research Center of Drug Discovery - member
- TMU Research Center of Cell Therapy and Regeneration Medicine - member
- TMU Research Center of Cancer Translational Medicine - Member
Person: Researcher
-
Bing-Chang Chen
- School of Respiratory Therapy - Professor
- Division of Pulmonary Medicine - Joint-Appointment Professor
- TMU Research Center of Thoracic Medicine - Associate Director
- TMU Research Center of Drug Discovery - member
Person: Researcher
-
Yu-Wen Cheng
- Department of Pharmaceutical Sciences - Professor
- Ph.D. Program in Drug Discovery and Development Industry - Joint-Appointment Professor
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine - Joint-Appointment Professor
- Master Program in Clinical Genomics and Proteomics - Joint-Appointment Professor
- Department of Ophthalmology - Joint-Appointment Professor
- TMU Research Center of Drug Discovery - Member
- TMU Research Center of Neuroscience - Member
Person: Researcher
-
Click Chemistry and Suzuki Coupling Approach for the Construction of Small Molecule Bifunctional Inhibitors Targeting the Dna Damage Repair Pathways.
Nepali, K. (PI)
8/1/24 → 7/31/27
Project: A - Government Institution › b - National Science and Technology Council
-
Integration of the Lung-On-A-Chip System to Establish a Physiologically Based Pharmacokinetic Model for Advancing the Development of Inhaled Small Interfering Rna Dosage Forms
Lai, M.-J. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
Discovery of Bbb-Crossing Drugs Targeting Neuroinflammation for Glioblastoma( III )
Liou, J.-P. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
Research output
-
3,4-dihydroxybenzalacetone from Phellinus linteus reduces glial activation, mitigates oxidative stress and inflammation, and preserves retinal function in ischemia–reperfusion-like injury
Wu, L. H., Kuo, Y. H., Lin, F. L., Fitriana, I., Yang, C. H., Shen, Y. C., Liu, Y. C., Jiang, C. Y., Yen, J. L., Lee, Y. M., Cheng, Y. W. & Hsiao, G., Jan 2026, In: Experimental Eye Research. 262, 110762.Research output: Contribution to journal › Article › peer-review
-
7,7”-dimethoxyagastisflavone induced MYCN/MYBL2-dependent apoptosis and metabolism reprogramming in Sonic Hedgehog medulloblastoma
Wu, Y. S., Lin, H. H., Wu, K. S., Huang, Y. T., Liao, J. Y., Chu, S. S., Wong, T. T., Hsieh, C. L., Chang, C. C., Sung, S. Y., Lin, C. Y. & Lin, Y. L., Dec 2026, In: Journal of Translational Medicine. 24, 1, 386.Research output: Contribution to journal › Article › peer-review
Open Access -
ADAM9 in tumor biology: molecular functions, clinical implications, and therapeutic targeting
Ho, K. H., Wu, C. J., Yang, Y. C. & Chien, M. H., Dec 2026, In: Cellular and Molecular Biology Letters. 31, 1, 74.Research output: Contribution to journal › Review article › peer-review
Open Access
Datasets
-
Additional file 4: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M.-W. (Contributor), Chang, L.-H. (Contributor), Tu, H.-J. (Contributor), Chang, C.-D. (Contributor), Lai, M.-J. (Contributor), Chen, Y.-Y. (Creator), Liou, J.-P. (Creator), Teng, C.-M. (Contributor) & Pan, S.-L. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.8202896.v1, https://springernature.figshare.com/articles/Additional_file_4_of_Combination_treatment_strategy_for_pancreatic_cancer_involving_the_novel_HDAC_inhibitor_MPT0E028_with_a_MEK_inhibitor_beyond_K-Ras_status/8202896/1
Dataset
-
Additional file 2: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M.-W. (Contributor), Chang, L.-H. (Contributor), Tu, H.-J. (Contributor), Chang, C.-D. (Contributor), Lai, M.-J. (Contributor), Chen, Y.-Y. (Creator), Liou, J.-P. (Creator), Teng, C.-M. (Contributor) & Pan, S.-L. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.8202887.v1, https://springernature.figshare.com/articles/Additional_file_2_of_Combination_treatment_strategy_for_pancreatic_cancer_involving_the_novel_HDAC_inhibitor_MPT0E028_with_a_MEK_inhibitor_beyond_K-Ras_status/8202887/1
Dataset
-
Additional file 1: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M.-W. (Contributor), Chang, L.-H. (Contributor), Tu, H.-J. (Contributor), Chang, C.-D. (Contributor), Lai, M.-J. (Contributor), Chen, Y.-Y. (Creator), Liou, J.-P. (Creator), Teng, C.-M. (Contributor) & Pan, S.-L. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.8202881.v1, https://springernature.figshare.com/articles/Additional_file_1_of_Combination_treatment_strategy_for_pancreatic_cancer_involving_the_novel_HDAC_inhibitor_MPT0E028_with_a_MEK_inhibitor_beyond_K-Ras_status/8202881/1
Dataset